Feb 2019 $20 M No. 5 $10 to $50 million 38
Blaze Bioscience, Inc.: Raise no. 5, Feb 2019 × Investors in this round 38 investors had bought by the notice of Apr 8, 2020: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $25 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Claudia Koch Jochheim · Executive Officer Dennis Cameron Miller · Executive Officer Heather Franklin · Executive Officer, Director Ludmila Cameron Lobanova · Executive Officer James Cameron Towne · Director Jan Koch Ohrstrom · Director Mary Ellen Hughes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ludmila Lobanova, SVP of Finance and Operations. Source: SEC Form D and 1 amendment, newest notice filed Apr 8, 2020. Read the notice at the SEC .
equity SEC May 2018 $3 M No. 4 $2 to $10 million 1
Blaze Bioscience, Inc.: Raise no. 4, May 2018 × Investors in this round 1 investor had bought by the notice of May 15, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Claudia Ellen Jochheim · Executive Officer Dennis C. Miller · Executive Officer Heather Franklin · Executive Officer, Director Ludmila C. Lobanova · Executive Officer James C. Towne · Director Jan Ellen Ohrstrom · Director Mary Ellen Hughes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ludmila Lobanova, Svp of finance and operations. Source: SEC Form D, newest notice filed May 15, 2018. Read the notice at the SEC .
debt, options SEC Oct 2017 $16 M No. 3 $10 to $50 million 32
Blaze Bioscience, Inc.: Raise no. 3, Oct 2017 × Investors in this round 32 investors had bought by the notice of Oct 10, 2017: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $18 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis C. Miller · Executive Officer Heather Franklin · Executive Officer, Director Ludmila C. Lobanova · Executive Officer James C. Towne · Director Jan Ellen Ohrstrom · Director Mary Ellen Hughes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ludmila Lobanova, Svp of finance and operations. Source: SEC Form D, newest notice filed Oct 10, 2017. Read the notice at the SEC .
equity SEC Jun 2013 $10 M No. 2 $2 to $10 million 27
Blaze Bioscience, Inc.: Raise no. 2, Jun 2013 × Investors in this round 27 investors had bought by the notice of Jun 25, 2015: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $15 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M Miller · Executive Officer Heather Franklin · Executive Officer, Director Julia C. Novak · Executive Officer Ludmila C. Lobanova · Executive Officer James C. Towne · Director James M. Olson · Director Jan Ellen Ohrstrom · Director Mary Ellen Hughes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offering of Series B Preferred Stock”Signed by Heather Franklin, President. Source: SEC Form D and 2 amendments, newest notice filed Jun 25, 2015. Read the notice at the SEC .
equity SEC Jun 2012 $6 M No. 1 $2 to $10 million 19
Blaze Bioscience, Inc.: Raise no. 1, Jun 2012 × Investors in this round 19 investors had bought by the notice of Jun 19, 2012: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $11 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Heather Franklin · Executive Officer, Director James C. Towne · Director James M. Olson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Heather Franklin, President. Source: SEC Form D, newest notice filed Jun 19, 2012. Read the notice at the SEC .
equity SEC